Cohen Capital Management Inc. boosted its stake in CME Group Inc. (NASDAQ:CME) by 0.7% during the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 34,040 shares of the company’s stock after buying an additional 250 shares during the period. Cohen Capital Management Inc.’s holdings in CME Group were worth $3,558,000 as of its most recent filing with the SEC.

Other hedge funds have also recently added to or reduced their stakes in the company. Gofen & Glossberg LLC IL boosted its stake in CME Group by 0.4% in the second quarter. Gofen & Glossberg LLC IL now owns 7,323 shares of the company’s stock valued at $713,000 after buying an additional 26 shares during the last quarter. Capstone Asset Management Co. boosted its stake in CME Group by 4.9% in the second quarter. Capstone Asset Management Co. now owns 29,334 shares of the company’s stock valued at $2,857,000 after buying an additional 1,372 shares during the last quarter. NN Investment Partners Holdings N.V. boosted its stake in CME Group by 4.5% in the second quarter. NN Investment Partners Holdings N.V. now owns 16,325 shares of the company’s stock valued at $1,590,000 after buying an additional 700 shares during the last quarter. Beacon Financial Group boosted its stake in CME Group by 0.8% in the second quarter. Beacon Financial Group now owns 4,525 shares of the company’s stock valued at $435,000 after buying an additional 38 shares during the last quarter. Finally, Hefty Wealth Partners boosted its stake in CME Group by 8.6% in the second quarter. Hefty Wealth Partners now owns 8,573 shares of the company’s stock valued at $835,000 after buying an additional 680 shares during the last quarter. 79.55% of the stock is owned by institutional investors and hedge funds.

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

CME Group Inc. (NASDAQ:CME) traded down 0.85% during midday trading on Monday, hitting $111.88. The company’s stock had a trading volume of 1,381,580 shares. The stock has a 50 day moving average of $106.96 and a 200 day moving average of $102.74. The company has a market cap of $37.97 billion, a PE ratio of 26.08 and a beta of 0.81. CME Group Inc. has a 52-week low of $81.87 and a 52-week high of $117.80.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Thursday, October 27th. The company reported $1.05 EPS for the quarter, topping the Zacks’ consensus estimate of $1.04 by $0.01. CME Group had a return on equity of 6.90% and a net margin of 41.54%. The firm earned $842 million during the quarter, compared to analyst estimates of $855.94 million. During the same period last year, the company earned $1.02 earnings per share. The business’s revenue for the quarter was down 1.0% on a year-over-year basis. On average, equities analysts expect that CME Group Inc. will post $4.35 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, December 28th. Stockholders of record on Friday, December 9th will be issued a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a dividend yield of 2.15%. The ex-dividend date of this dividend is Wednesday, December 7th. CME Group’s payout ratio is currently 55.94%.

COPYRIGHT VIOLATION WARNING: “Cohen Capital Management Inc. Raises Stake in CME Group Inc. (CME)” was published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this report on another website, it was illegally stolen and republished in violation of U.S. and international copyright laws. The original version of this report can be accessed at https://www.thecerbatgem.com/2016/11/28/cohen-capital-management-inc-raises-stake-in-cme-group-inc-cme.html.

Several equities analysts have weighed in on the company. JPMorgan Chase & Co. cut CME Group from an “overweight” rating to a “neutral” rating and set a $116.00 price objective for the company. in a report on Monday, November 14th. They noted that the move was a valuation call. Jefferies Group lifted their price objective on CME Group from $112.00 to $118.00 and gave the company a “buy” rating in a report on Wednesday, August 31st. Zacks Investment Research cut CME Group from a “buy” rating to a “hold” rating in a report on Wednesday, September 7th. Deutsche Bank AG lifted their price objective on CME Group from $115.00 to $116.00 and gave the company a “buy” rating in a report on Wednesday, October 5th. Finally, RBC Capital Markets set a $92.00 price objective on CME Group and gave the company a “sell” rating in a report on Friday, October 28th. Three equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have given a buy rating to the company. The company has an average rating of “Hold” and a consensus target price of $102.89.

In related news, CEO Terrence A. Duffy sold 17,375 shares of the stock in a transaction on Friday, November 25th. The stock was sold at an average price of $112.58, for a total value of $1,956,077.50. Following the sale, the chief executive officer now owns 127,739 shares in the company, valued at $14,380,856.62. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Dennis Suskind sold 2,000 shares of the stock in a transaction on Wednesday, November 2nd. The stock was sold at an average price of $100.52, for a total value of $201,040.00. Following the completion of the sale, the director now owns 8,499 shares in the company, valued at approximately $854,319.48. The disclosure for this sale can be found here. 0.61% of the stock is owned by insiders.

About CME Group

CME Group Inc is a provider of products across all major asset classes, based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals. The Company’s products include both exchange-traded and privately negotiated futures and options contracts and swaps. The Company connects buyers and sellers together through its CME Globex electronic trading platform across the globe and its open outcry trading facilities in Chicago and New York City.

5 Day Chart for NASDAQ:CME

Receive News & Stock Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related stocks with our FREE daily email newsletter.